Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 3/20 | 0.43 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.42 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4337764 | 0.87 | HSD17B10 (0.59) | SLC6A9HAO1ALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL11757879 | 0.81 | SLC6A4 (0.51) | SLC6A9HAO1PDE7AIDO1PDE7B | |
| SCHEMBL28424052 | 0.81 | PDE7A (0.54) | ALDH1A1HSD17B10CYP3A4MEN1KMT2A | |
| SCHEMBL29465671 | 0.81 | PDE7A (0.54) | ALDH1A1HSD17B10CYP3A4MEN1KMT2A | |
| SCHEMBL4336372 | 0.81 | HAO1 (0.39) | SLC6A9HAO1ALOX15HTT | |
| SCHEMBL4337657 | 0.80 | SLC6A9 (0.43) | SLC6A9HAO1ALDH1A1MEN1KMT2A | |
| SCHEMBL11758399 | 0.79 | SLC6A9 (0.47) | SLC6A9ALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL11760048 | 0.78 | SLC6A4 (0.43) | SLC6A9HAO1PLA2G1BATG4BPDE7A | |
| SCHEMBL11759128 | 0.77 | SLC6A9 (0.43) | SLC6A9HAO1ALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL4335576 | 0.77 | SLC6A9 (0.47) | SLC6A9HAO1ALDH1A1HPGDPDE7A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612068-B2 | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives | H. LUNDBECK A/S (DK) | 2009-11-03 | — | — | US | disclosed |
| CN-100439330-C | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives | LUNDBECK & CO AS H (DK) | 2008-12-03 | — | — | CN | disclosed |
| US-20060235003-A1 | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives | H. LUNDBECK A/S (DK) | 2006-10-19 | — | — | US | disclosed |
| CN-1780815-A | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives | LUNDBECK & CO AS H (DK) | 2006-05-31 | — | — | CN | disclosed |
| EP-1622868-A1 | AROMATIC OXYPHENYL AND AROMATIC SULFANYLPHENYL DERIVATIVES | H. LUNDBECK A/S (DK) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004096761-A1 | AROMATIC OXYPHENYL AND AROMATIC SULFANYLPHENYL DERIVATIVES | H. LUNDBECK A/S (DK) | 2004-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235003-A1 | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives | TYR, TPST2, COMT | SLC6A9 2305/4885HAO1 1672/4885ALDH1A1 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.